UPM Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in late-stage commercial manufacturing of semi-solid and oral solid dose pharmaceuticals. They operate from a large-scale cGMP and FDA-guided manufacturing facility in Bristol, Tennessee, offering services such as technology transfer, scale-up support, quality and regulatory support, formulation and analytical development, packaging, warehousing, and specialized handling capabilities including controlled substances and high-potent materials. UPM focuses on propelling customers' journeys to market by providing personalized service, expertise in technology transfer, and a passion for creating pharmaceutical solutions tailored to each project's commercial goals.